Molina Healthcare (MOH)
(Delayed Data from NYSE)
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $306.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $306.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
Why HCA Holdings (HCA) is Likely to Beat on Earnings in Q4
by Zacks Equity Research
We expect HCA Holdings Inc. (HCA) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Jan 31.
Will Aflac (AFL) Disappoint Investors this Earnings Season?
by Zacks Equity Research
Aflac Inc. (AFL) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 after the closing bell.
Anthem (ANTM) Q4 Earnings: A Beat in Store for the Stock?
by Zacks Equity Research
We expect Anthem Inc. (ANTM) to beat expectations when it reports fourth-quarter results on Feb 1 before the market opens.
Is Disappointment in Store for Aetna (AET) in Q4 Earnings?
by Zacks Equity Research
Aetna Inc. (AET) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 before the opening bell.
Will PerkinElmer (PKI) Disappoint this Earnings Season?
by Zacks Equity Research
PerkinElmer Inc. (PKI) is expected to report fourth-quarter 2016 results on Feb 2, 2017.
Will Baxter International (BAX) Disappoint in Q4 Earnings?
by Zacks Equity Research
Baxter International Inc. (BAX) is scheduled to report fourth-quarter 2016 earnings on Feb 1, before the opening bell.
The Zacks Analyst Blog Highlights: UnitedHealth, Aetna, Molina HealthCare and Centene
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Aetna, Molina HealthCare and Centene
Henry Schein (HSIC) Q4 Earnings: Disappointment in Store?
by Zacks Equity Research
Henry Schein, Inc. (HSIC) is expected to report fourth-quarter 2016 financial numbers on Feb 8, before the opening bell.
Will Trump's Executive Order Rattle Healthcare Market?
by Zacks Equity Research
Donald Trump has signed an executive order in relation to the Affordable Care Act (ACA) or the more popularly called Obamacare.
Teladoc (TDOC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Telehealth provider, Teladoc Inc. (TDOC ) is scheduled to report fourth-quarter and full-year 2016 results on Jan 27.
4 Reasons Why WellCare Health Stock is a Great Pick Now
by Zacks Equity Research
In spite of the possibility of the reform affecting WellCare Health's business, the company remains an attractive pick for investors.
AmerisourceBergen (ABC) Q1 Earnings: Will It Disappoint?
by Zacks Equity Research
AmerisourceBergen Corp. (ABC) is set to report first-quarter fiscal 2017 results on Jan 31, before the opening bell.
C.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store?
by Zacks Equity Research
Delving deeper into the fundamentals of C.R. Bard (BCR), let's see how things are shaping up prior to this quarter.
Is a Surprise in Store for Hologic (HOLX) in Q1 Earnings?
by Zacks Equity Research
Hologic Inc. (HOLX) is slated to report first-quarter fiscal 2017 financial results on Feb 1, after the closing bell.
Myriad Genetics (MYGN) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Myriad Genetics, Inc.(MYGN) is expected to report second-quarter fiscal 2017 results on Feb 7, after the closing bell.
IDEXX Laboratories (IDXX) Q4 Earnings: What's in Store?
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) is slated to report fourth-quarter 2016 results on Feb 2, before the opening bell.
Will Boston Scientific (BSX) Pull a Surprise in Q4 Earnings?
by Zacks Equity Research
Boston Scientific Corporation (BSX) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Feb 2.
Edward Lifesciences (EW): What's in Store in Q4 Earnings?
by Zacks Equity Research
Edward Lifesciences Corp. (EW) is scheduled to report fourth-quarter and full-year 2016 earnings results after market close on Feb 1, 2017.
Illumina (ILMN) Q4 Earnings: A Beat in Store for the Stock?
by Zacks Equity Research
We expect Illumina Inc (ILMN) to beat expectations when it reports fourth-quarter 2016 results after the closing bell on Jan 31.
UnitedHealth (UNH) Beats on Q4 Earnings, Enrollment Grows
by Zacks Equity Research
UnitedHealth's (UNH) earnings of $2.11 per share, beat the Zacks Consensus Estimate of $2.07. Earnings improved 50.7% year over year.
Coupa Completes Acquisition of Spend360 International
by Zacks Equity Research
Coupa Software Inc. (COUP) recently completed the acquisition of U.K based Spend360 International for an undisclosed amount.
Is Obamacare on its Way Out?
by Arpita Dutt
Healthcare stocks like will remain in focus as the "repeal Obamacare" situation plays out.
Humana (HUM) to Write off Receivables; Updates Guidance
by Zacks Equity Research
Humana Inc. (HUM) recently announced its decision to write off its receivables of $591 million associated with the risk corridor premium stabilization program outstanding as of Sep 30, 2016.
Humana, FullWell to Enhance Value-Based Care in Colorado
by Zacks Equity Research
Humana Inc. (HUM) recently announced that it has entered in to a value-based agreement with population health leader, FullWell
Molina Helathcare's (MOH) 2017 Star Quality Ratings Raised
by Zacks Equity Research
Molina Healthcare Inc.'s (MOH) eligible health plans have either been raised or have remained unchanged in terms of the 2017 Star Ratings by Centers for Medicare & Medicaid Services ("CMS").